Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- Controversy around the definition of PCOS continues
-
- Technology, education key to glucose control in ICU
- Does PCOS increase risk for CVD?
- What is needed to help improve implementation of intensive insulin therapy in the ICU?
- Treating a patient with gynecomastia Ronald Tamler, MD, PhD, MBA
- Uvulitis in a pediatric patient with diabetes James H. Brien, DO
- Social demands on people with diabetes can limit time for self-care Guadalupe C. Heredia, RN, CDE, BSN, PHN
- Lower extremity ulcerations: Presenting the facts Patris Toney, DPM, MPH
- What is the cause of ‘dead in bed’ syndrome? David S.H. Bell, MB, FACE, FACP
-
- Endocrine University: no fellow left behind Suzanne Myers Adler, MD
- Auscultation and the stethoscope
- Diagnostic dilemma: Papillary thyroid carcinoma and multiple pulmonary nodules Sara M. Pietras, MD; Stephanie L. Lee, MD, PhD, ECNU
- New FDA rules may prompt Pig Latin drug names Richard O. Dolinar, MD
- Antidepressant use, progression to diabetes linked
- Bone fractures less likely in patients with hyperglycemia
- Breast cancer risk low in women with Turner’s syndrome
- Genes are responsible for more than three-fourths of abdominal adiposity, BMI
-
- Higher MI rates found with calcium supplements
- Low levels of paternal monitoring affected adolescents’ HbA1c
- Meta-analysis estimates disparity in HbA1c for Hispanic patients
- Outpatient nephrologic care resulted in fewer deaths in patients with diabetes, CKD
- Prevalence of metabolic syndrome high in Hispanic youth
- Prevalence of metabolic syndrome higher in boys, older children
- Threefold breast cancer risk linked with hormone therapy
- Well-preserved insulin resistance does not accelerate onset of type 1 diabetes
-
- WHI follow-up study confirms combined HT risks outweigh benefits
- Diabetes education, self-management, still key
- Target identification offers a promising approach for type 2 diabetes therapeutics
- Bariatric surgery: Treatment modality for metabolic disease Dara P. Schuster, MD
- Endocrinologist turned author, TV host and patient education advocate
- Premixed analog insulin: What is the tradeoff between convenience and achievement of target HbA1c? June Felice Johnson, BS, PharmD, FASHP, CDM-diabetes